Clinical trial

Domperidone in Secondary Progressive Multiple Sclerosis (SPMS)

NCT02308137

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-02-01

PhasePHASE2

Study timeline

Study start (actual)2015-02-01Date precision: month

Registry last updated2020-02-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosis, Secondary Progressiveunresolved

Interventions

DomperidoneDRUG

Sponsors & collaborators

University of Calgarylead sponsor

Alberta Innovates Health Solutionscollaborator

Mapped research locations

CalgaryAlberta, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02308137 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.